中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

高脂饮食诱导非酒精性脂肪性肝病小鼠模型肝脏microRNA表达谱的变化分析

麦静愔 陈天阳 成扬

引用本文:
Citation:

高脂饮食诱导非酒精性脂肪性肝病小鼠模型肝脏microRNA表达谱的变化分析

DOI: 10.3969/j.issn.1001-5256.2017.12.023
基金项目: 

上海浦东新区卫生系统学科带头人培养计划(PWRd2016-01); 上海市卫生和计划生育委员会项目(201540181); 

详细信息
  • 中图分类号: R-332;R575.5

Changes in microRNA expression profile in the liver of mice with nonalcoholic fatty liver disease induced by high-fat diet

Research funding: 

 

  • 摘要:

    目的研究microRNA(miRNA)-384的表达对高脂饮食诱导非酒精性脂肪性肝病(NAFLD)小鼠肝脂肪变性的影响。方法将30只雄性C57BL/6J小鼠适应性喂养7 d,然后随机分成2组,每组15只。对照组中的15只小鼠给予普通饮食,模型组15只小鼠给予HFD,喂养8周后获取肝组织。进行HE和尼罗红染色观察肝组织病理改变。采用微阵序列测序肝组织的全基因组miRNA表达谱,PCR法测定miRNA-384的相对表达水平。计量资料2组间比较采用t检验。结果对照组小鼠肝脏呈红色,边缘锐利,肝小叶结构清晰,肝细胞无脂肪变性;模型组小鼠肝脏呈黄色,边缘变钝,肝细胞明显肿胀,细胞质内可见大量脂肪空泡,脂滴相互融合导致细胞核偏位。与正常小鼠相比,在NAFLD小鼠的肝组织中发现了12个上调和18个下调的miRNA。筛查了对照组和模型组间的一些差异表达的miRNA,获得同样的聚类分析图。在这8个明显改变的miRNA中,miRNA-384具有显著的倍数变化。结论 miRNA-384表达的上调与肝脏脂肪变性有着密切关系,但是其作用机制仍需进一步研究。

     

  • [1]CHENG Y, HOU T, PING J, et al.Quantitative succinylome analysis in the liver of non-alcoholic fatty liver disease rat model[J].Proteome Science, 2016, 14 (1) :1-11.
    [2]CHENG Y, GONG YH, ZHANG YH, et al.Effect of Jianpi Liqi Huatian Recipe Granule on FFA, HOMA-IR and APRI in patients with spleen deficiency and hypertrophic nonalcoholic steatohepatitis[J].Chin J Exp Med Formul, 2017, 23 (17) :200-204. (in Chinese) 成扬, 龚亚华, 张银华, 等.健脾理气化湿方配方颗粒治疗脾虚湿热型非酒精性脂肪性肝炎患者疗效及对FFA, HOMA-IR, APRI的影响[J].中国实验方剂学杂志, 2017, 23 (17) :200-204.
    [3]HU ZJ, ZHANG J.China's non-alcoholic fatty liver disease research status[J].J Clin Hepatol, 2016, 32 (3) :552-556. (in Chinese) 胡中杰, 张晶.我国非酒精性脂肪性肝病的研究现状[J].临床肝胆病杂志, 2016, 32 (3) :552-556.
    [4]AMBROS V.The functions of animal microRNAs[J].Nature, 2004, 431 (7006) :350-355.
    [5]CHEN W, CHEN HH.MicroRNAs and liver diseases[J].J Commun Med, 2012, 10 (24) :40-42. (in Chinese) 陈汶, 陈宏辉.microRNAs与肝脏疾病[J].社区医学杂志, 2012, 10 (24) :40-42.
    [6]TAKAHASHI K, YAN I, WEN HJ, et al.microRNAs in liver disease:from diagnostics to therapeutics[J].Clin Biochem, 2013, 46 (10) :946-952.
    [7]PAN L, ZHANG JB, CUI RG, et al.Establishment of nonalcoholic fatty liver C57BL/6 mouse model[J].Chin J Tissue Engineer Res, 2016, 20 (40) :6054-6059. (in Chinese) 潘磊, 张金彪, 崔荣岗, 等.非酒精性脂肪肝C57BL/6小鼠模型的建立[J].中国组织工程研究, 2016, 20 (40) :6054-6059.
    [8]ALY FZ, KLEINER D.Update on fatty liver disease and steatohepatitis[J].Adv Anat Pathol, 2011, 18 (4) :294-300.
    [9]DAY CP, JAMES OF.Steatohepatitis:a tale of two"hits"?[J].Gastroenterology, 1998, 114 (4) :842-845.
    [10]CHEN ZW, CHEN LY, DAI HL, et al.Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease[J].J Zhejiang Univ Sci B, 2008, 9 (8) :616-622.
    [11]XIN SL, XU KS.Non-alcoholic fatty liver disease pathogenesis new understanding[J].J Clin Hepatol, 2017, 33 (8) :1581-1583. (in Chinese) 辛晟梁, 徐可树.非酒精性脂肪性肝病发病机制新认识[J].临床肝胆病杂志, 2017, 33 (8) :1581-1583.
    [12] LIANG X.The relationship between microRNA-122 and the pathogenesis of fatty liver disease[D].Guangzhou:Guangzhou Med Coll, 2012. (in Chinese) 梁霞.微小RNA-122与脂肪性肝病发病关系的实验研究[D].广州:广州医学院, 2012.
    [13]ZHANG Y, JIANG Y, QI FX.miRNA in chronic liver disease and its clinical significance[J].World Chin J Dig, 2014, 22 (28) :4257-4262. (in Chinese) 张颖, 江勇, 齐凤祥.miRNA在慢性肝病中的变化及其临床意义[J].世界华人消化杂志, 2014, 22 (28) :4257-4262.
    [14]LI ZW, WU T, FU YX, et al.Expression and roles of MicroRNA-31 in HCC[J].Chin J Clin Pharmacol Ther, 2015, 20 (10) :1098-1101. (in Chinese) 李中文, 吴涛, 付应霄, 等.MicroRNA-31在肝癌中的表达和作用[J].中国临床药理学与治疗学, 2015, 20 (10) :1098-1101.
    [15]FENG M, E CY, LI H, et al.Expression of miR-196a in liver cancer cells and its promotion effect on proliferation[J].J Jilin Univ:Med Edit, 2015, 41 (1) , 120-124. (in Chinese) 冯默, 鄂长勇, 李航, 等.miR-196a在肝癌细胞中的表达及其促增殖作用[J].吉林大学学报:医学版, 2015, 41 (1) :120-124.
    [16]LI M, XIE HQ, XIONG W, et al.The role of MicroRNA in regulation of substance metabolism[J].J Central South Uni Med Edit, 2013, 38 (3) :318-322. (in Chinese) 李明, 谢慧清, 熊武, 等.MicroRNA在调控物质代谢方面的作用[J].中南大学学报医学版, 2013, 38 (3) :318-322.
    [17]WANG YD, ZHAO CY.MicroRNA in liver disease research and application[J].Basic Clin Med, 2009, 29 (2) :216-219. (in Chinese) 王亚东, 赵彩彦.MicroRNA在肝病中的研究与应用[J].基础医学与临床, 2009, 29 (2) :216-219.
    [18]LI S, XU YN, NIU X, et al.MiRNAs were used to screen differentially expressed miRNAs in the liver of different age pigs[J].China Anim Husb Veter Med, 2017, 44 (3) :673-678. (in Chinese) 李升, 许亚楠, 牛熙, 等.利用miRNA芯片筛选不同月龄香猪肝脏中差异表达的miRNA[J].中国畜牧兽医, 2017, 44 (3) :673-678.
    [19]MA YH, XING HC.MicroRNA in liver fibrosis research progress[J/CD].Chin J Liver Dis:Electronic Edition, 2017, 9 (2) :1-4. (in Chinese) 马艳华, 邢卉春.microRNA在肝纤维化中的研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (2) :1-4.
    [20]LI ZH.miRNA on molecular control of nonalcoholic fatty liver disease[D].Beijing:Beijing Univ Chem Technol, 2016. (in Chinese) 李泽浩.miRNA对非酒精性脂肪肝病变的分子调控作用[D].北京:北京化工大学, 2016.
  • 加载中
计量
  • 文章访问数:  2153
  • HTML全文浏览量:  24
  • PDF下载量:  421
  • 被引次数: 0
出版历程
  • 收稿日期:  2017-08-18
  • 出版日期:  2017-12-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回